Fidelity
Home > Boards > Free Zone > All Trading - Technical > Money Runners

SNPK AND MONEY RUNNERS WILL NOT BE Buying

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
HotStockAce Member Profile
Member Level 
Followed By 3,980
Posts 80,085
Boards Moderated 8
Alias Born 03/25/07
160x600 placeholder
Johnson & Johnson Earnings Rise 35%
Johnson & Johnson earns $4.73 billion, or $1.64 a share, led by continued sales growth in its pharmaceutical business. Revenue increased 3.5% to $18.12 billion. It also lifted its EPS estimate range for the year.
More Top Equities Stories Of The Day
GM's Barra Unveils Further Plans to Improve Safety
Glencore Xstrata Buys Caracal -- Update
Citi Picks Dewilde to Lead Asia Markets and Investor Services Business
Sales of Johnson s New Hepatitis Drug Soars
Twitter Co-Founders, CEO Won't Sell Shares -- 2nd Update
Columnist Joanna Stern answers readers' technology questions
Surgical Device Maker ConMed Exploring Sale -Reuters
Yahoo Shows Signs of Growth
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist